[1]SorianoV , Garcia-SamaniegoJ .ImpactofchronicliverdiseaseduetohepatitisvirusesascauseofhospitaladmissionanddeathinHIV -infect eddrugusers[J].EurJEpidemiol, 1999, 15∶1-4.
|
[2]病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19∶56-62.
|
[3]ShermanK , RoustrerS , ChungR , etal.HepatitisC :prevalenceinHIV-infectedpatientsacrosssectionalanalysisoftheUSACTG[J].AntiviralTher, 2000, 5 (Suppl.1) ∶64-65.
|
[4]HaganH , ThiedeH .Sharingofdrugpreparationequipmentasariskfac torforhepatitisC[J].AmJPublicHealth, 2001, 91∶42-46.
|
[5]罗端德.传染病讲座[M].北京:人民卫生出版社, 2002∶114~122.
|
[6]EysterME , DiamondstoneLS .NaturalhistoryofhepatitisCvirusinfec tioninmultitransfusedhemophiliacs:effectofcoinfectionwithhumanim munodeficiencyvirus.TheMulticenterHemophiliaCohortStudy[J].JAcquirImmuneDeficSyndr, 1993, 6 (6) ∶602-10.
|
[7]MassimoPuoti, MaurizioBonacini.LiverFibrosisProgressionIsRelatedtoCD4CellDepletioninPatientsCoinfectedwithHepatitisCVirusandHumanImmunodeficiencyVirus[J].JInfectDis, 2001, 183∶134-137.
|
[8]王克霞, 李朝品, 王建.丙肝患者PBMCMil-2R及T细胞亚群检测[J].吉首大学学报 (自然科学版) , 2001, 22 (4) ∶79-82.
|
[9]CernyA , McHutchisonJG , PasquinelliC , etal.CytotoxicTlymphocyteresponsetohepatitisCvirus-derivedpeptidescontainingtheHLAA21bindingMoti[J].JClinInvest, 1995, 95∶521-530.
|
[10]MullerHM , PfaffE , GoefferT , etal.PeripheralLeukocytesServeasaPossibleExtrahelaticSiteforHepatitisCvirusReplication[J].JGenVirol, 1993, 74 (4) ∶699-676.
|
[11]王健, 张荣波, 许礼发, 等.HCV侵染患者外周血单个核细胞后对细胞免疫功能的影响[J].安徽医科大学学报, 1999, 34 (2) ∶103-105.
|